Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
30.19
-0.84 (-2.71%)
At close: Aug 26, 2026, 4:00 PM EDT
30.82
+0.63 (2.07%)
After-hours: Aug 26, 2026, 7:58 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $3.02 billion as of August 26, 2026. Its market cap has increased by 86.72% in one year.
Market Cap
3.02B
Enterprise Value
2.11B
1-Year Change
86.72%
Ranking
Category
Stock Price
$30.19
ChartMarket Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $3.02B, an increase of 819.82%. That is a compound annual growth rate of 40.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 3.02B | 10.27% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 3.11B |
| Disc Medicine | 3.11B |
| Alumis | 2.98B |
| SELLAS Life Sciences Group | 2.89B |
| Zai Lab | 2.88B |
| AtaiBeckley | 2.74B |
| Nurix Therapeutics | 2.73B |
| Viridian Therapeutics | 2.72B |